Asthma and COPD share similar breathing symptoms, often leading to confusion and misdiagnosis. Know key differences, risks of ...

CEO Barry Quart told investors at Oppenheimer’s 36th Annual Healthcare Life Science Conference that the company is advancing ...

ABP Live Doc Talk: Most of the patients come into the clinic with complaints of asthma, particularly when they have chronic cough, breathlessness, or wheezing. From a doctor's perspective, a main ...

Mepolizumab reduces moderate to severe COPD exacerbations in patients with varying blood eosinophil counts and type 2 inflammation.

Cough sounds carry disease-specific acoustic signatures. By analysing these signatures using an AI-based algorithm, the ...

Proton pump inhibitor (PPI) use in patients with chronic obstructive airway diseases is associated with an increased exacerbation risk.

There are more than 170 rhinoviruses known to science. These causes of the common cold are found in noses all around you, and ...

New digital health apps for asthma and COPD, including COPDhub and Asthmahub, now support patients across West Yorkshire with symptom management ...

Malaysia has a new national plan to tackle cancer, tuberculosis, and chronic respiratory conditions in a single approach. Jacqui Thornton reports.

Both dupilumab and mepolizumab were originally approved for asthma but were subsequently studied in patients with COPD who continue to experience symptoms and moderate-to-severe exacerbations despite ...

Zydus Lifesciences has launched PEPair™, India's first affordable Oscillating Positive Expiratory Pressure device for chronic lung conditions.